UBS Oncology Impact Fund L.P., 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 26,814 shares at $20.21 ($541K) on 2021-05-21, disclosed to the SEC on 2021-05-24.
Open-market sale of $541k HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.21 | 10,907 | $220K | 40.7% |
| 2 | $20.21 | 10,907 | $220K | 40.7% |
| 3 | $20.12 | 5,000 | $101K | 18.6% |
| Total | $20.19 avg | 26,814 | $541K | 100% |
| Filing → |
| HOWL | SELL | 2025-10-29 | $685K | — | Filing → |
| ITOS | SELL | 2021-09-27 | $3.2M | — | Filing → |
| CGEM | SELL | 2021-09-02 | $1.3M | — | Filing → |